Skip to main content

Table 1 Preoperative data comparison table

From: Risk factors for deep vein thrombosis of the lower extremity after total hip arthroplasty

factor

DVT group(n = 65)

Non-DVT group(n = 397)

X2/t-value

p-value

age(x¯±s)

67.27 ± 4.10

66.72 ± 8.69

8.668

0.616

sex (man/woman, n)

21/44

141/256

0.253

0.615

BMI(x¯±s, kg/m2)

23.83 ± 3.79

23.40 ± 3.79

0.034

0.854

The affected limb(Left/Right, n)

32/33

214/183

0.490

0.484

Smoking history(n/%)

13(19.89%)

120(30.12%)

2.850

0.091

Drinking history(n/%)

13(19.89%)

106(26.60%)

1.311

0.252

hypertension(n/%)

13(19.89%)

97(24.346%)

0.605

0.437

diabetes(n/%)

24(36.72%)

92(23.09%)

5.615

0.018

Preoperative total cholesterol(x¯±s, mmol/L)

5.10 ± 0.91

4.94 ± 1.12

1.726

0.190

Preoperative triglycerides(x¯±s, mmol/L)

1.44 ± 0.73

1.45 ± 1.18

1.598

0.207

Preoperative fibrinogen(x¯±s, g/L)

3.25 ± 0.98

3.78 ± 1.20

6.457

0.011

Preoperative hemoglobin(x¯±s, g/L)

123.24 ± 21.56

121.29 ± 21.46

0.150

0.699

Preoperative albumin(x¯±s, g/L)

40.21 ± 4.62

39.17 ± 4.51

0.231

0.631

Preoperative platelet(x¯±s, 109/L)

223.92 ± 65.70

198.42 ± 78.72

1.271

0.260

Preoperative D-dimer(x¯±s, mg/L)

0.67 ± 0.81

0.58 ± 0.47

19.255

0.000

Preoperative INR(x¯±s)

1.07 ± 0.13

1.03 ± 0.11

8.403

0.004

Preoperative fibrin degradation products(x¯±s, ug/mL)

1.40 ± 1.35

3.79 ± 1.88

20.980

0.000

  1. There was a statistically significant difference between the two groups (P<0.05)